サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1654671

世界のリポソームサプリメント市場-2025-2033年

Global Liposomal Supplements Market - 2025-2033

出版日
ページ情報
英文 165 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.63円
世界のリポソームサプリメント市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 165 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のリポソームサプリメント市場は、2024年に9億347万米ドルに達し、2033年には1兆5,680億米ドルに達すると予測され、予測期間2025-2033年のCAGRは6.3%で成長します。

リポソームはリン脂質二重層からなる小さな小胞で、ドラッグデリバリーの医薬品用途に広く使用されています。いくつかのサプリメントは、安定性を高め、消化管環境から保護し、全体的な吸収を改善するために、リポソームにカプセル化することができます。

天然の細胞膜に似たリポソームは、従来の製剤に比べ、サプリメントを直接血流に乗せ、細胞内に取り込むことを可能にし、より高い生物学的利用能（バイオアベイラビリティ）を保証します。脂溶性ビタミン、水溶性ビタミン、ミネラルのほとんどすべてを、リポソーム担体を用いて体内に送り込むことができます。

リポソームサプリメント市場は、新規リポソーム技術の開発やサプリメント消費の増加などの要因により、将来的に有利な成長が見込まれています。

市場力学：

促進要因と抑制要因

サプリメント消費の増加

リポソームサプリメント市場は、栄養補助食品消費の増加によって大きく牽引されると予想されます。消費者は栄養補助食品による健康効果を認識するようになり、その多くが定期的な摂取を始めています。この10年間では、COVID-19の大流行が栄養補助食品の消費増加の主な原動力の一つとなっています。この間、人々は明らかにその健康効果を実感し、いくつかの人口集団が摂取を続けています。例えば、2023年7月にMDPI Nutrients Journalに掲載された論文によると、COVID-19の大流行中、ビタミンCの消費量は40％近く急増し、マルチビタミンの消費量は82％増加しました。

リポソーム技術は、医薬品のドラッグデリバリーとしては古くから確立されていますが、栄養補助食品への採用は最近増加しています。この先端技術を用いたビタミン、ミネラル、その他の栄養補助食品の製剤化は、メーカー各社で採用が進んでいます。さらに、消費者はリポソーム製剤が従来のものより優れていることを認識しつつあります。このことは、予測期間においてリポソームサプリメントの採用を促進すると予想されます。

リポソーム型ビタミン・ミネラルに対する消費者の認識が限定的であることが、市場の成長を抑制する可能性があります。

栄養補助食品に対する消費者基盤は高いが、高度なリポソーム技術を用いたビタミン・ミネラルの採用率は低いです。これは、健康上のメリットに関する認識が低いことに加え、コストが高いためです。特に農村部に住む特定の人口グループでは、こうした栄養補助食品を入手する機会が少なく、その存在に気づいていない可能性が高いです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • サプリメントの消費増加
      • 先進的リポソーム技術の開発の開発
    • 抑制要因
      • 消費者の認知度の低さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • 価格分析
  • パイプライン分析
  • 特許分析
  • 規制分析

第6章 製品タイプ別

  • ビタミン
    • ビタミンA
    • ビタミンB
    • ビタミンC
    • ビタミンD
    • ビタミンE
    • ビタミンK
  • 鉱物
    • 鉄
    • 亜鉛
    • マグネシウム
    • 銅
    • その他
  • アミノ酸・タンパク質
  • 必須脂肪酸
  • プロバイオティクス・プレバイオティクス
  • その他

第7章 剤形別

  • カプセル
  • タブレット
  • グミ
  • サシェ
  • その他

第8章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第9章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第10章 企業プロファイル

  • liposovit.com
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • LipoCellTech
  • Liposoma BV
  • Solaray
  • NOW（R）Foods
  • Rho Nutrition
  • LivOn Labs
  • YourZooki
  • Pure Encapsulations
  • Quicksilver Scientific, Inc.
  • Valimenta
  • Henry Blooms.
  • AFT Pharmaceuticals.
  • Lipolife
  • Similar data will be provided for each market player.

第11章 付録

目次
Product Code: PH9105

The global Liposomal supplements market reached US$ 903.47 million in 2024 and is expected to reach US$ 1,568.00 billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.

Liposomes are small vesicles made up of phospholipid bilayer and are widely used in pharmaceutical applications for drug delivery. Several supplements can be encapsulated in liposomes to enhance their stability, protect them from the gastrointestinal environment, and improve their overall absorption.

The liposomes which resemble the natural cell membrane enable supplements to enter the bloodstream directly, and then into cells ensuring higher bioavailability, as compared to traditional formulations. Almost all the fat-soluble vitamins, water-soluble vitamins, and minerals can be delivered into the body using liposomal carriers.

The market for liposomal supplements is expected to see lucrative growth in the future driven by factors such as the rising development of novel liposome technologies and the rising consumption of supplements

Market Dynamics: Drivers & Restraints

The rising consumption of supplements

The market for liposomal supplements is expected to be significantly driven by the rising consumption of dietary supplements. Consumers are becoming more aware of the health benefits caused by these dietary supplements and many of them have started the regular consumption practice. In this decade, Covid-19 pandemic is one of the major driver for the increased consumption of dietary supplements. During this period, people have evidently seen their health benefits, and several population groups have continued taking them. For instance, As per the article published in July 2023, in MDPI Nutrients Journal, during Covid-19 pandemic, nearly as surge of 40% in vitamin C consumption, 82% increase in multivitamin consumption was obsereved.

The liposomal technology, although long established for pharmaceutical drug delivery, its adoption for dietary supplements is growing in recent times. Formulation of vitamins, minerals, and other dietary supplements using this advanced technology is a practice that is being increasingly adopted by manufacturers. Moreover, consumers are becoming more aware of the advantages offered by liposomal forms over traditional ones. This is anticipated to drive the adoption of liposomal supplements in the forecast period.

Limited consumer awareness of liposomal vitamins and minerals may restrain the market growth.

Although the consumer base for dietary supplements is high, the adoption rate of vitamins and minerals made using advanced liposomal technology is lower. This is due to a lack of awareness regarding the health benefits, and also the higher cost. This is especially high in certain population groups living in rural areas who may have less access to these dietary supplements and may be unaware of their existence.

Segment Analysis

The global liposomal supplements market is segmented based on Product Type, Dosage Form, and region.

Vitamins in the product type segment have the highest market share in the U.S. liposomal vitamins and minerals market.

Vitamins are the most commonly used dietary supplements in across the globe. All the vitamins are essential micronutrients, and they play a crucial role in maintaining overall health and well-being. The human body cannot produce the majority of the vitamins, and to maintain proper functioning, they must be obtained from external sources like diet and supplementation.

Dietary supplements are consumed by all types of populations to promote their health and well-being. Among these vitamins are the most widely consumed dietary supplements. For instance, a survey published in the Journal of American Heart Association, in May 2024 stated that among the population with atherosclerotic cardiovascular disease, the vitamin intake is higher. 35.4% of the survey population reported regular consumption of multivitamins, and 30.8% reported regular consumption of Vitamin D. This represents the demand for vitamins among patients suffering from chronic diseases.

Geographical Analysis

North America is expected to hold a significant share and grow with a highest CAGR in the forecast period.

North America region is well known for its advanced healthcare and wellness industry. The population in the U.S. are highly aware of the health benefits of dietary supplements and the consumer base for these products is huge. For instance, as per the Council for Responsible Nutrition (CRN) 2023 Survey data, 74% of U.S. adults consume dietary supplements and 55% of adults consume them regularly.

Additionally, North America, especially U.S. holds significant proportion of market players who are innovating novel liposomal technologies and are launching advanced formulations. For instance, In May 2024, Vida Lifescience announced the launch of new nano-liposomal products notably Nano-Liposomal Vitamin C (3000mg) Drink Mix and Nano-Liposomal Glutathione (750mg) Drink Mix in the U.S. market. These are the proprietary brands of Aurora Nutrascience, and Vida has the exclusive rights to distribute its products in the U.S. market. In January 2025, Renue by Science has launched a new range of supplements for skin health under the brand name Renue Blue. These products are made with cutting-edge ingredients and nanoliposome technology.

The huge consumer base for supplements in the U.S. coupled with advanced product launches drives the adoption of liposomal supplements in the region.

Competitive Landscape

The major global players in the Liposomal supplements market are liposovit.com, LipoCellTech, Liposoma BV, Solaray, NOW(R) Foods, Rho Nutrition, LivOn Labs, YourZooki, Pure Encapsulations, Quicksilver Scientific, Inc., Valimenta, Henry Blooms., AFT Pharmaceuticals. and Lipolife among others.

Key Developments

  • In January 2025, Jiva Technologies has launched new website www.LIV3Health.com, for LIV3 Health, which marks the commencement of LIV3's flagship SugarShield supplement presale orders. The platform serves as an early gateway for health-conscious consumers to secure the LIV3's supplements. The shipments to customers are expected to begin in Q1 of 2025.
  • In July 2024, Immod announced the launch of new line of supplements called Cell Boost & Balance - CellBB. These advanced supplements are made of patented blend of liposomal phospholipids which are aimed at boosting cellular health, and support immunity.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Product Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Product Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Liposomal supplements market report would provide approximately 66 tables, 51 figures, and 165 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Dosage Form
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Consumption of Supplements
      • 4.1.1.2. Rising Development of Advanced Liposomal Technologies
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Consumer Awareness
    • 4.1.3. Opportunities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Pricing Analysis
  • 5.3. Pipeline Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Vitamins*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Vitamin A
    • 6.2.4. Vitamin B
    • 6.2.5. Vitamin C
    • 6.2.6. Vitamin D
    • 6.2.7. Vitamin E
    • 6.2.8. Vitamin K
  • 6.3. Minerals
    • 6.3.1. Iron
    • 6.3.2. Zinc
    • 6.3.3. Magnesium
    • 6.3.4. Copper
    • 6.3.5. Others
  • 6.4. Amino Acids & Proteins
  • 6.5. Essential Fatty Acids
  • 6.6. Probiotics & Prebiotics
  • 6.7. Others

7. By Dosage Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 7.1.2. Market Attractiveness Index, By Dosage Form
  • 7.2. Capsules*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Tablets
  • 7.4. Gummies
  • 7.5. Sachets
  • 7.6. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Spain
      • 8.3.5.5. Italy
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. South Korea
      • 8.5.5.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. liposovit.com*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals etc.
    • 10.1.5. SWOT Analysis
  • 10.2. LipoCellTech
  • 10.3. Liposoma BV
  • 10.4. Solaray
  • 10.5. NOW(R) Foods
  • 10.6. Rho Nutrition
  • 10.7. LivOn Labs
  • 10.8. YourZooki
  • 10.9. Pure Encapsulations
  • 10.10. Quicksilver Scientific, Inc.
  • 10.11. Valimenta
  • 10.12. Henry Blooms.
  • 10.13. AFT Pharmaceuticals.
  • 10.14. Lipolife
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us